IntroWe specialize in metabolic therapeutics, dedicating our efforts to innovating treatment methodologies for metabolic disorders such as type 2 diabetes and obesity. Our objective is to shift the paradigm of managing metabolic diseases as chronic symptoms towards establishing lasting, disease-modifying therapies. These therapies are specifically designed to address the fundamental organ-level origins of type 2 diabetes and obesity. We are confident in the substantial clinical and economic potential that lies in pioneering novel strategies capable of bringing about a significant advancement, aiming to target and potentially reverse the underlying pathological factors of these conditions.